1. Organization WH. Childhood lead poisoning. 2010.
2. Mehrpour O, Karrari P, Abdollahi M. Chronic lead poisoning in Iran; a silent disease. Daru 2012;20:8.
3. Karrari P, Mehrpour O, Abdollahi M. A systematic review on status of lead pollution and toxicity in Iran; Guidance for preventive measures. Daru 2012;20:2.
4. Alinejad S, Aaseth J, Abdollahi M, Hassanian-Moghaddam H, Mehrpour O. Clinical Aspects of Opium Adulterated with Lead in Iran: A Review. Basic Clin Pharmacol Toxicol 2018;122:56-64.
5. Afshari R, Emadzadeh A. Short communication: case report on adulterated opium-induced severe lead toxicity. Drug Chem Toxicol 2010;33:48-9.
6. Domeneh BH, Tavakoli N, Jafari N. Blood lead level in opium dependents and its association with anemia: A cross-sectional study from the capital of Iran. J Res Med Sci 2014;19:939-43.
7. Meybodi FA, Eslick GD, Sasani S, Abdolhoseyni M, Sazegar S, Ebrahimi F. Oral opium: an unusual cause of lead poisoning. Singapore Med J 2012;53:395-7.
8. Soltaninejad K, Flückiger A, Shadnia S. Opium addiction and lead poisoning. J Subst Use 2011;16:208-12.
9. Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S, Amirabadizadeh AR, Zahedi MJ, et al. Lead poisoning among opium users in Iran: an emerging health hazard. Subst Abuse Treat Prev Policy 2017;12:43.
10. Ghaderi A, Vahdati-Mashhadian N, Oghabian Z, Moradi V, Afshari R, Mehrpour O. Thallium exists in opioid poisoned patients. Daru 2015;23:39.
11. Salehi H, Sayadi AR, Tashakori M, Yazdandoost R, Soltanpoor N, Sadeghi H, et al. Comparison of serum lead level in oral opium addicts with healthy control group. Arch Iran Med 2009;12:555-8.
12. Afzali S, Torabian S, Taheri SK. Do Opium Abusers Develop Lead Toxicity? A Study on Opium Abusers in Hamadan, Iran. Asia Pac J Med Toxicol 2017;:55-8.
13. Farzaneh E, Amani F, Etemad F. A Clinico-Epidemiologic Study on Patients with Opium Toxicity Treated at Ardabil Hospitals, Iran, 2014-2015. Asia Pac J Med Toxicol 2016;5:111-4.
14. Ghaemi N, Alikhani S, Bagheri S, Sezavar M. A Cross Sectional Study of Opioid Poisoning in Children at a Tertiary Center. Asia Pac J Med Toxicol 2016;5:115-8.
15. Kianoush S, Sadeghi M, Balali-Mood M. Recent Advances in the Clinical Management of Lead Poisoning. Acta Med Iran 2015;53:327-36.
16. Wang C, Liang J, Zhang C, Bi Y, Shi X, Shi Q. Effect of ascorbic Acid and thiamine supplementation at different concentrations on lead toxicity in liver. Ann Occup Hyg 2007;51:563-9.
17. Sajitha G, Jose R, Andrews A, Ajantha K, Augustine P, Augusti K. Garlic oil and vitamin E prevent the adverse effects of lead acetate and ethanol separately as well as in combination in the drinking water of rats. Indian J Clin Biochem 2010;25:280-8.
18. Caylak E, Aytekin M, Halifeoglu I. Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol 2008;60:289-94.
19. Wang L, Wang Z, Liu J. Protective effect of N-acetylcysteine on experimental chronic lead nephrotoxicity in immature female rats. Hum Exp Toxicol 2010;29:581-91.
20. Flora SJ, Pachauri V. Chelation in metal intoxication. Int J Environ Res Public Health 2010;7:2745-88.
21. Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, et al. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. Expert Opin Drug Metab Toxicol 2017;13:279-92.
22. Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev 2015;55:294-321.
23. Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, et al. The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med 2009;103:434-41.
24. Cazzola M, Calzetta L, Page C, Jardim J, Chuchalin AG, Rogliani P, et al. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev 2015;24:451-61.
25. Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 2013;1830:4117-29.
26. Chen W, Ercal N, Huynh T, Volkov A, Chusuei CC. Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment. J Colloid Interface Sci 2012;371:144-9.
27. Sisombath NS, Jalilehvand F. Similarities between N-Acetylcysteine and Glutathione in Binding to Lead (II) Ions. Chem Res Toxicol 2015;28:2313-24.
28. Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006;11:114.
29. Froutan H, Kashefi Zadeh A, Kalani M, Andrabi Y. Lead toxicity: a probable cause of abdominal pain in drug abusers. Med J Iran 2011;25:16-20.
30. Dobrakowski M, Pawlas N, Kasperczyk A, Kozlowska A, Olewinska E, Machon-Grecka A, et al. Oxidative DNA damage and oxidative stress in lead-exposed workers. Hum Exp Toxicol 2017;36:744-54.
31. Mandegary A, Sezavar M, Saeedi A, Amirheidari B, Naghibi B. Oxidative stress induced in the workers of natural gas refineries, no role for GSTM1 and GSTT1 polymorphisms. Hum Exp Toxicol 2012;31:1271-9.
32. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-74.
33. Pourgholamhossein F, Sharififar F, Rasooli R, Pourgholi L, Nakhaeipour F, Samareh-Fekri H, et al. Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation of pro-fibrotic genes and inhibition of oxidative stress. Environ Toxicol Pharmacol 2016;45:340-5.
34. Pourgholamhosein F, Rasooli R, Pournamdari M, Pourgholi L, Samareh-Fekri M, Ghazi-Khansari M, et al. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression. Food Chem Toxicol 2018;112:39-46.
35. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol1990;186:464-78.
37. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol1999;299:15-27.
38. Aykin-Burns N, Franklin EA, Ercal N. Effects of N-acetylcysteine on lead-exposed PC-12 cells. Arch Environ Contam Toxicol 2005;49:119-23.
39. Flora G, Gupta D, Tiwari A. Toxicity of lead: A review with recent updates. Interdiscip Toxicol 2012;5(2):47-58.
40. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem2001;1:529-39.
41. Hermes-Lima M. How do Ca2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? Free Radic Biol Med 1995;19:381-90.
42. Bechara EJ. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Braz J Med Biol Res 1996;29:841-51.
43. Hermes-Lima M, Valle VG, Vercesi AE, Bechara EJ. Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning. Biochim Biophys Acta 1991;1056:57-63.
44. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000;29(10):927-45.
45. Flora SJ, Pande M, Kannan GM, Mehta A. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol (Noisy-le-grand) 2004;50 Online Pub:OL543-51.
46. Flora SJ, Pande M, Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 2003;145:267-80.
47. Pande M, Flora SJ. Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology 2002;177:187-96.
48. Gautam P, Flora SJ. Oral supplementation of gossypin during lead exposure protects alteration in heme synthesis pathway and brain oxidative stress in rats. Nutrition 2010;26:563-70.
49. Ercal N, Treeratphan P, Hammond TC, Matthews RH, Grannemann NH, Spitz DR. In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radic Biol Med 1996;21:157-61.
50. Ottenwälder H, Simon P. Differential effect of N-acetylcysteine on excretion of the metals Hg, Cd, Pb and Au. Arch Toxicol 1987;60:401-2.
51. Banner W Jr, Koch M, Capin DM, Hopf SB, Chang S, Tong TG. Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds. Toxicol Appl Pharmacol 1986;83:142-7.
52. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003;60:6-20.
53. Flora SJ, Mittal M, Mehta A. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res 2008;128:501-23.
54. Mukherjee TK, Mishra AK, Mukhopadhyay S, Hoidal JR. High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione. J Immunol 2007;178:1835-44.
55. Zhang H, Liu Y, Liu R, Liu C, Chen Y. Molecular Mechanism of Lead-Induced Superoxide Dismutase Inactivation in Zebrafish Livers. J Phys Chem B 2014;118:14820-6.